Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Bajaj HealthCare Limited
BAJAJHCARE | NSE
311.70
INR21.60
7.45%
BAJAJHCARE | NSE
Loading StockChartView...
About Bajaj HealthCare Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
01/04/2026
Close
311.70
Open
303.20
High
316.80
Low
294.15
Bajaj HealthCare Limited a pharmaceutical company develops manufactures and supplies amino acids nutritional supplements and active pharmaceutical ingredients (APIs) for pharmaceutical nutraceuticals and food industries in India and internationally. The company's product portfolio consists of various APIs in the therapeutic categories of anti-diabetic antibiotic antiviral antiplatelet antifungal antihelmintic iron-chelating agent anticonvulsant growth stimulant non-steroidal anti-inflammatory drugs antihypertensive anthelmintics anti-asthmatic antioxidant urinary tract infection anti-histamine weight reducing venous disease antimalarial vitamin c disinfectant/ antiseptic stimulant anticonvulsant lipotropic agents nootropic vasoprotective/ antihemorrhagic cardiovascular agents food supplements anti-anemic amino acids antiasthmatic / bronchodilator nutritional supplement and minerals. It also provides formulations in the form of tablets capsules and oral powder as well as intermediates and impurities. In addition the company exports its products. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane India.
View LessBAJAJHCARE | NSE
Risk
61.6
Sharpe
-1.47
Luna's Score
43/100
Recommendation
Sell
Luna says (BAJAJHCARE | NSE)
What's Working
Low Market Beta (-0.4 to 0.8)
What's not Working
High Short-term Volatility
Microcap (<300M USD)
High Debt to Equity (> 0.75)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
82.1%1 month
61.6%3 months
46.6%6 months
38.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.33
Debt to equity
1.20
Debt to assets
0.43
Ent. to EBITDA
35.04
Ent. to rev.
3.24
PEG
-
Other Fundamentals
EBITDA
834.83M
MarketCap
9.79B
MarketCap(USD)
105.04M
Div. yield
0.26
Op. margin
13.44
Erngs. growth
-79.50
Rev. growth
1.90
Ret. on equity
-4.44
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
47.80
Range1M
54.75
Range3M
156.75
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.39
Price X volume
40.26M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 35.04 | 24.85 | Expensive |
| Ent. to Revenue | 3.24 | 11.40 | Cheaper |
| PE Ratio | - | 51.36 | - |
| Price to Book | 4.33 | 6.83 | Cheaper |
| Dividend Yield | 0.26 | 0.52 | Poor |
| Std. Deviation (3M) | 46.58 | 42.17 | Par |
| Debt to Equity | 1.20 | 0.35 | Expensive |
| Debt to Assets | 0.43 | 0.17 | Expensive |
| Market Cap | 9.79B | 290.82B | Emerging |
